Johns Hopkins researchers have identified a biological process that may explain why some childhood bone injuries permanently disrupt growth, and they found a way to interrupt it in mice using a drug already approved for other uses.
The finding concerns growth plates, the soft cartilage regions near the ends of children's long bones where new bone is produced. When a growth plate is injured, a bridge of solid bone sometimes forms across it. That structure, called a bony bar, can tether the bone and cause it to grow short or crooked.
In research published in Science Translational Medicine, a team led by pathologist Aaron W. James found that a rapid invasion of sensory nerve fibers and blood vessels into the injured growth plate appears to drive bony bar formation. Inhibiting those nerves with long-acting bupivacaine, an FDA-approved anesthetic, reduced abnormal bone growth by up to 60 percent at six weeks compared with untreated controls.
One distinction matters. The researchers observed sensory nerve growth in injured growth plates in both mouse and human tissue. The treatment result is mouse-only. No child has been treated this way, and the anesthetic has not been shown to prevent growth disturbance in humans.
Healthy Growth Plates Keep Nerves Out
The biology here is genuinely surprising, and it explains why the finding is significant rather than incremental.
Growth plate cartilage normally contains essentially no nerve fibers and no blood vessels. Until now, the role of sensory nerves in detecting and regulating growth plate injury was unknown.
After injury, that exclusion breaks down. Sensory nerves and blood vessels rush in together, in regions corresponding to where nerve growth factor is expressed, and the researchers found that this invasion promotes the abnormal bone formation that becomes a bony bar.
The team traced the effect to TrkA-positive sensory neurons, the same population James's laboratory had previously implicated in skeletal injury response, and identified pleiotrophin as the signal those neurons send to launch abnormal bone growth. That mechanism was supported by single-cell RNA sequencing, organ culture, and knockout experiments in sensory ganglia before the drug was tested.
In a healing fracture, nerve-driven bone formation is what you want. In an injured growth plate, the same cascade builds bone where cartilage needs to remain.
Why Growth Plate Injuries Worry Pediatric Surgeons
For parents, the underlying clinical problem is worth understanding, because it is more common than the research language suggests.
Growth plates are among the weakest parts of a growing skeleton, which is why children sustain growth plate fractures where an adult would sustain a ligament tear. Most heal without lasting consequence.
A minority do not. When a bony bar forms, the affected side of the bone stops lengthening while the rest continues, producing progressive limb length discrepancy or angular deformity. Because the consequence unfolds over months and years of continued growth, it often is not apparent at the time of the original injury.
Current treatment is largely surgical and reactive. A related Hopkins paper on injury models notes that existing clinical treatments carry significant limitations. Options include resecting the bony bar and inserting material to prevent it from reforming, procedures to correct angulation, or operations to slow growth on the opposite side. Results are variable and the interventions are substantial for a child.
That is the gap this research addresses. A treatment given at the time of injury that reduced bony bar formation would prevent the problem rather than correct it, which is a categorically different proposition. The researchers also note the approach could address pain alongside preserving growth.
The Distance Between a Mouse and a Child
The drug involved makes this feel closer to the clinic than most preclinical findings, and that impression needs tempering.
Bupivacaine is an established local anesthetic already used in children, including in orthopedic procedures, and a long-acting formulation exists. That familiarity means the safety profile of the compound itself is comparatively well characterized, which can shorten some parts of a development path.
It does not mean the application is ready. What was tested in mice was inhibition of a specific neuronal population at a specific site and time after a controlled injury, using a dosing approach designed for the model. Translating that to a child involves questions the study did not address: what dose and timing would apply, whether blocking these nerves would impair the desirable parts of bone healing, and whether repeated or sustained blockade would be required.
Mouse bone biology differs from human bone biology in growth rate, plate closure timing, and mechanical loading. Preclinical orthopedic findings frequently do not reproduce in people. The researchers describe the work as proof of concept supporting further research, and the study title specifies mouse models. It was supported by National Institutes of Health funding.
What Parents Should Do About a Suspected Growth Plate Injury
Nothing in this research changes care today. Standard guidance does apply, and it matters.
Any injury near a joint in a child that produces persistent pain, swelling, tenderness directly over the bone end, inability to bear weight or use the limb, or visible deformity warrants medical evaluation. Growth plate fractures are not always visible on initial X-rays, so persistent symptoms after a normal X-ray still deserve follow-up rather than reassurance.
Ask specifically whether a growth plate was involved and whether follow-up imaging is planned. Children with growth plate fractures are often monitored over time precisely because a bony bar can appear later, and a scheduled recheck is the mechanism by which it gets caught early.
Watch for asymmetry in the months and years afterward: a limb that looks shorter, a joint that angles differently, or a change in gait. Report those to a clinician rather than waiting for a scheduled visit.
Do not delay evaluation of a child's injury on the theory that children heal quickly. The growth plate is the reason that reasoning fails. This article is general information and is not a diagnosis.
MedicalDaily will report any progression of this work toward human testing.
Frequently Asked Questions
What is a bony bar? A bridge of solid bone that can form across an injured growth plate, tethering it and disrupting normal bone growth.
What did the researchers find? Sensory nerve fibers and blood vessels rapidly invaded injured growth plates, seen in both mouse and human tissue, and in mice this promoted bony bar formation.
What was the treatment? Long-acting bupivacaine, an FDA-approved anesthetic, was used to inhibit TrkA-positive sensory neurons. It reduced abnormal bone growth by up to 60 percent in mice.
Does this work in children? Unknown. The treatment was tested only in mice, and the anesthetic has not been shown to prevent growth disturbance in humans.
How common are growth plate injuries? Common in children, since growth plates are weaker than surrounding bone. Most heal without lasting consequence.
How are bony bars treated now? Largely surgically, including resection with interposition material or procedures to correct resulting deformity.
What should I watch for after my child's injury? Persistent pain or swelling, and later, limb length differences, angulation, or gait changes.
